Journal article
Booster vaccination against SARS-CoV-2 induces potent immune responses in people with human immunodeficiency virus
- Abstract:
-
Background
People with human immunodeficiency virus (HIV) on antiretroviral therapy (ART) with good CD4 T-cell counts make effective immune responses following vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). There are few data on longer term responses and the impact of a booster dose.Methods
Adults with HIV were enrolled into a single arm open label study. Two doses of ChAdOx1 nCoV-19 were followed 12 months l... Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 1.3MB, Terms of use)
-
- Publisher copy:
- 10.1093/cid/ciac796
Authors
Funding
Bibliographic Details
- Publisher:
- Oxford University Press
- Journal:
- Clinical Infectious Diseases More from this journal
- Volume:
- 76
- Issue:
- 2
- Pages:
- 201-209
- Place of publication:
- United States
- Publication date:
- 2022-10-05
- Acceptance date:
- 2022-08-31
- DOI:
- EISSN:
-
1537-6591
- ISSN:
-
1058-4838
- Pmid:
-
36196614
Item Description
- Language:
-
English
- Keywords:
- Pubs id:
-
1281618
- Local pid:
-
pubs:1281618
- Deposit date:
-
2023-07-06
Terms of use
- Copyright holder:
- Fidler et al.
- Copyright date:
- 2023
- Rights statement:
- © The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
- Licence:
- CC Attribution (CC BY)
Metrics
If you are the owner of this record, you can report an update to it here: Report update to this record